PTPRC and COVID-19: LPS-induced CD45 expression was lower in COVID-19 patients than in healthy volunteers in all three investigated cell types, suggesting a downregulation of the Toll-like receptor-4-mediated signal transduction pathway in COVID-19, at least in respect to CD45.